Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jingzhi Tong"'
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundNumerous studies showed that insulin resistance (IR) was associated with cancer risk. However, few studies investigated the relationship between IR and non-small cell lung cancer (NSCLC). The aim of this study is to explore the association
Externí odkaz:
https://doaj.org/article/ebd1f85cc4104fd19f68b50dcaa3805b
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:1269-1273
Autor:
Xianhua Gui, Shi Shenyun, Hui Ding, Rujia Wang, Jingzhi Tong, Min Yu, Tingting Zhao, Miao Ma, Jingjing Ding, Xiaoyan Xin, Yuying Qiu, Xiaohua Qiu, Yingwei Zhang, Min Cao, Mei Huang, Mengshu Cao, Jinghong Dai, Hourong Cai, Yonglong Xiao
Publikováno v:
Rheumatology. 61:4570-4578
Objectives In the present study, we aimed to assess the prevalence and clinical significance of anti-Ro52 antibodies in a cohort of patients with idiopathic inflammatory myopathy-associated interstitial lung disease (IIM-ILD) with different myositis-
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundNumerous studies showed that insulin resistance (IR) was associated with cancer risk. However, few studies investigated the relationship between IR and non-small cell lung cancer (NSCLC). The aim of this study is to explore the association
Autor:
Jingzhi Tong, Qing He, Jing Yang, Xiaojun Ren, Min Wang, Yang Ying, Zhaowei Meng, Hui Li, Ming Liu, Zuoliang Dong, Jinhong Sun, Min Deng
Publikováno v:
The Journal of clinical endocrinology and metabolism. 104(10)
ContextEvidence indicates that there is substantial impairment/loss of β-cell function/mass even before prediabetes. Elevated plasma proinsulin is a sign of β-cell dysfunction in patients with diabetes/prediabetes. However, the dynamic changes of g
Autor:
Jinghua He, Ke Sun, Dan Chen, Xiaodong Wang, Keqiu Li, Yi Kang, Guang Li, Jingzhi Tong, Zhaoyan Qiang, Wen Ding, Yingxi Li, Yaqing Jing
Publikováno v:
Immunologic Research. 64:988-1000
Regulatory dendritic cells are a potential therapeutic tool for assessing a variety of immune overreaction diseases. Paeoniflorin, a bioactive glucoside extracted from the Chinese herb white paeony root, has been shown to be effective at inhibiting t
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2016 (2016)
Evidence-Based Complementary and Alternative Medicine, Vol 2016 (2016)
Recently, regulatory dendritic cells (DCregs), a newly described dendritic cell subset with potent immunomodulatory function, have attracted increased attention for their utility in treating immune response-related diseases, such as graft-versus-host